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This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based 
research. The summary is not intended to be a comprehensive summary of available evidence on 
COVID-19 but aims to make original documents easily accessible to decision makers which, if 
relevant to them, they should go to before making decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
25.09.2020 Viral presence 
and 
immunopathology 
in patients with 
lethal COVID-19: 
a prospective 
autopsy cohort 
study 
The Lancet 
Microbe | 
Article 
• Extensive systemic 
inflammatory 
response was 
present in patients 
with lethal COVID-19 
• SARS-CoV-2-
infected cells were 
only sporadically 
present at late 
stages of C19 
suggesting a 
maladaptive immune 
response 
substantiating the 
evidence for 
immunomodulation 
as a target in the 
treatment of severe 
C19 
Systemic 
inflammatory 
response 
24.09.2020 Auto-antibodies 
against type I 
IFNs in patients 
with life-
threatening 
COVID-19 
Science | 
Article 
• Out of 987 ICU 
patients with life-
threatening C19 
pneumonia, 101 had 
auto-antibodies 
against type I IFNs. 
37 of these patients 
died.  
• No auto-antibodies 
against type I IFNs 
Auto-
antibodies 
were found in 663 
patients with 
asymptomatic or 
mild SARS-CoV-2 
infection 
• Severe COVID-19 is 
associated with 
auto-antibodies 
against type I 
interferon but 
causality and 
direction of causality 
is not shown 
• Autoantibodies to 
IFN may be a useful 
biomarker of severe 
disease that could 
be used to guide 
clinical care. These 
autoantibodies could 
also be target by 
novel drugs to treat 
C19 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
25.09.2020 Susceptibility 
to SARS-
CoV-2 
infection 
among 
children and 
adolescents 
compared 
with adults: A 
systematic 
review and 
meta-analysis 
JAMA 
Pediatrics | 
systematic 
review and 
meta-analysis 
• Included 32 studies 
• Preliminary evidence 
suggests that children 
and adolescents 
younger than 20 years 
have a lower 
susceptibility to SARS-
CoV-2 infection (44% 
lower odds of 
secondary infection) 
compared with adults 
• Data were insufficient 
to conclude whether 
transmission of SARS-
CoV-2 by children is 
lower than by adults 
Susceptibility, 
transmission, 
children 
17.09.2020 Transmission 
of SARS-
CoV-2: A 
review of 
viral, host, 
and 
Annals of 
Internal 
Medicine | 
Review 
• A comprehensive 
review of the evidence 
on transmission of 
SARS-CoV-2 
• Strong evidence from 
case and cluster 
reports indicates that 
respiratory 
transmission 
environmental 
factors  
transmission is 
dominant, with 
proximity and 
ventilation being key 
determinants of 
transmission risk 
• Infectiousness peaks 
around a day before 
symptom onset and 
declines within a week 
of symptom onset 
• The virus has 
heterogeneous 
transmission dynamics 
with most people not 
transmitting virus, 
whereas some cause 
many secondary cases 
in clusters 
Therapeutics 
Publication 
date 
Title/URL Journal/Articl
e type 
Summary             Keywords 
18.09.2020 Mortality 
outcomes with 
hydroxychloroqui
ne and 
chloroquine in 
COVID-19: an 
international 
collaborative 
meta-analysis of 
randomized trials 
medRxiv | 
pre-print (not 
peer 
reviewed) 
• Rapid meta-
analysis of 
ongoing, 
completed, or 
discontinued 
RCTs on 
hydroxychloroqui
ne or chloroquine 
treatment for any 
C19 patients  
• No benefit of 
hydroxychloroqui
ne or chloroquine 
on the survival of 
C19 patients was 
found 
• For 
hydroxychloroqui
ne, the 
confidence 
interval is 
compatible with 
increased 
mortality (OR 
1.18) or negligibly 
reduced mortality 
(OR 0.99) 
Hydroxychloroqui
ne, chloroquine 
• Generalisability to 
outpatients, 
children, pregnant 
women, and 
people with 
comorbidities is 
unclear 
Vaccines 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
23.09.2020  SARS-CoV-
2 vaccines in 
development 
Nature | 
Review 
• There are currently more 
than 180 SARS-CoV-2 
vaccines in various stages 
of development 
• Data available so far 
suggests that effective and 
safe vaccines might 
become available within 
months 
 vaccines 
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
23.09.2020 COVID-
19 and 
violence 
against 
women 
and 
children: 
a second 
research 
round up 
CGD | Notes 
• Round up of 28 news studies 
that have been released sine the 
last summary 
• Most studies focus on the 
question: Have violence levels 
increased during COVID-19? 
• There is increasing evidence 
that the C19 pandemic and 
associated policy responses 
increase VAW/C across 
contexts. Where there is mixed 
or decreasing trends, emerging 
evidence suggests that this may, 
in part, be due to underreporting 
• Additional attention and 
reporting on ethics is needed to 
ensure a ‘do no harm’ approach 
with increasing numbers of 
studies on primary data 
VAW/C 
collection and often using 
remote survey methodologies 
• Rather than simply examining 
trends, future studies should 
prioritise “actionable” research 
informing evidence-based policy 
and financing responses, 
including possible prevention 
and mitigation measures 
 Leadership and governance 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
24.09.2020 Lessons 
learnt from 
easing 
COVID-19 
restrictions: 
an analysis 
of countries 
and regions 
in Asia 
Pacific and 
Europe 
The Lancet | 
Health Policy 
• This Health Policy papers 
using an adapted 
framework to examine the 
approaches taken by nine 
high-income countries and 
regions that have started to 
ease C19 but aims to 
facilitate cross-country 
learning so included in this 
summary 
Lessons, 
easing 
restrictions 
Health systems 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
23.09.2020 How previous 
epidemics 
enable 
timelier 
COVID-19 
responses: 
an empirical 
study using 
organisational 
memory 
theory 
BMJ Global 
Health | 
Original 
research 
• There has been little 
systematic exploration 
into what affects 
timeliness of epidemic 
response, despite the 
potential for earlier 
responses to be more 
effective 
• Results from this study 
show that exposure to 
any major epidemic was 
associated with an 
approx. 6-10 days earlier 
response  
Timeliness, 
epidemic 
response 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type 
26.09.2020 Offline: COVID-19 is not a pandemic The Lancet | Comment 
26.09.2020 COVID-19 in India: the dangers of false 
optimism 
The Lancet Editorial 
25.09.2020 It’s time to put children and young people 
first during the global COVID-19 pandemic 
JAMA Pediatrics | Editorial 
25.09.2020 What matters most for policy now: better 
mortality data 
CGD | Blog 
25.09.2020 Reclaiming comprehensive public health BMJ Global Health | Commentary 
25.09.2020 COVID-19 vaccination: returning to WHO’s 
Health For All 
The Lancet Global Health | 
Comment 
24.09.2020 Saliva or nasopharyngeal swab specimens 
for detection of SARS-CoV-2 
NEJM | Correspondence 
24.09.2020 Willingness to comply with physical 
distancing measures against COVID-19 in 
four African countries 
BMJ Global Health | Commentary 
24.09.2020 Challenges and priorities for delivering on 
the Beijing Declaration and Platform for 
Action 25 years on 
The Lancet Comment 
22.09.2020 COVID-19 clinical trials: learning from 
exceptions in the research chaos 
Nature Medicine | 
Correspondence 
21.09.2020 For an equitable COVID-19 response, 
investments in civil society cannot wait  
UHC2030 | Blog 
21.09.2020 SARS-CoV-2 transmission dynamics should 
inform policy 
SSRN  
18.09.2020 New findings confirm global disruptions in 
essential health services for women and 
children from COVID-19 
GFF | News 
15.09.2020 Adjustments in health purchasing as part of 
the COVID-19 health response: results of a 
short survey and lessons for the future 
P4H | Blog 
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Dashboards & Trackers 
Cases & deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living evidence & 
policy maps 
Current research 
including trials 
  Diagnostics   Treatments   Vaccines 
WHO sitreps  WHO Africa  Ghana  COVID-NMA  WHO    FIND SARS-
CoV-2 Test 
Tracker 
  Global COVID-
19 Clinical Trial 
Tracker 
  CEPI 
WHO dashboard  African 
Arguments  
Indonesia  EPPI Centre  WHO International 
Clinical Trials 
Registry Platform 
(ICTRP)  
 FIND SARS-
CoV-2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre LSHTM  
Johns Hopkins 
University  
European 
CDC  
Nigeria CDC  Norwegian 
Institute of Public 
Health  
Cytel   Serology-based 
tests for COVID-
19 
  Solidarity trial  COVID-19 
Oxford 
Vaccine Trial 
WEF    Sierra Leone   Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH   Our World in 
Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-19 
Vaccine 
Tracker 
Our World in 
Data  
  Singapore   Our World in 
Data: C19 Policy 
responses 
COVID-evidence        
Global 5050    UK   IFPRI COVID-19 
Policy Response 
Portal 
Cochrane        
CEBM, University 
of Oxford  
  US   COVID-19 
Primer 
Clinicaltrials.gov        
Humanitarian 
Data Exchange  
     NIH LitCovid  UKCDR       
Information is 
Beautiful  
     WHO COVID-19 
Database 
        
LSHTM                
HealthMap 
(cases) 
              
The Commons 
Project 
              
SeroTracker                
   
 Evidence Summary 
y 
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health Topics   Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashing 
in low resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparedness 
Innovations 
  Social 
Development 
Direct C19 blog 
series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
Health 
Policy and 
Planning  
Norwegian 
Institute of Public 
Health 
    
COVID-19 
Digest 
UNHCR  South 
African 
Government 
JAMA 
Network 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The 
Lancet 
 HEART     
UNESCO   medRxiv 
and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford 
University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   SAGE 
journals 
 Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David Nabarro 
  Springer 
Nature 
      
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetMap 
Team 
  Wiley       
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global Impact 
Study 
    
  
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
02.10.2020 Understanding and 
Improving COVID-19 
Vaccine Portfolio 
Online event 1h30 CGD 
21.09.2020 Mitigating the 
Economic and Health 
Impact of COVID-19 
across Africa 
Online event 1h30 CGD, GF, AU 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid weekly search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary research 
papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease control 
and health system responses are included. Articles related to tackling the secondary impacts on other sectors are 
not included. Additional commentaries, opinions, and commissioned pieces are selected based on relevance. 
  
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report  
This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before making 
decisions. The HES are not intended to replace medical or professional advice and the researcher or the K4D 
consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES alone. 
K4D services are provided by a consortium of leading organisations working in international development, led by 
the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield 
Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of 
Birmingham International Development Department (IDD) and the University of Manchester Humanitarian and 
Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Foreign, Commonwealth 
and Development Office (FCDO) and its partners in support of pro-poor programmes. Except 
where otherwise stated, it is licensed for non-commercial purposes under the terms of the 
Open Government Licence v3.0. K4D cannot be held responsible for errors, omissions or 
any consequences arising from the use of information contained in this health evidence 
summary. Any views and opinions expressed do not necessarily reflect those of FCDO, K4D 
or any other contributing organisation.  
© Crown copyright 2020. 
 
